NDC product
Vicks ZzzQuil NIGHT PAIN NIGHTTIME SLEEP-AID PAIN RELIEVER
NDC 84126-372 · The Procter & Gamble Manufacturing Company
Key facts
| Product NDC | 84126-372 |
|---|---|
| Proprietary name | Vicks ZzzQuil |
| Nonproprietary name | Diphenhydramine HCl, Acetaminophen |
| Substances | DIPHENHYDRAMINE HYDROCHLORIDE, ACETAMINOPHEN |
| Dosage form | LIQUID |
| Route | ORAL |
| Labeler | The Procter & Gamble Manufacturing Company |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M010 |
| Pharmacologic classes | Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC] |
| Marketing start | Feb 3, 2026 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: